NCT02722083View on ClinicalTrials.gov

Exploratory Study for Allergy Relief Onset

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

May 7, 2016

Primary Completion Date

May 27, 2016

Study Completion Date

July 13, 2016

Conditions

Rhinitis, Allergic

Interventions

DRUG

Chlorpheniramine maleate (BAY X002134)

4 mg tablet, single dose, orally

DRUG

Placebo

placebo tablet, single dose, orally

Trial Locations (1)

38138

Germantown

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY